Actively Recruiting
Use of Glubran 2 ® in Axillary Lymphadenectomy Without Drain
Led by Omphis Foundation · Updated on 2024-09-04
134
Participants Needed
1
Research Sites
217 weeks
Total Duration
On this page
Sponsors
O
Omphis Foundation
Lead Sponsor
C
Consorci Sanitari del Maresme
Collaborating Sponsor
AI-Summary
What this Trial Is About
Axillary lymphadenectomy in breast cancer continues to be a common practice in certain patients. The use of sealants and drains continues to be a source of disagreement among the scientific community. That is why the study was designed to show whether the sealant reduces seroma after axillary lymphadenectomy without drainage.
CONDITIONS
Official Title
Use of Glubran 2 ® in Axillary Lymphadenectomy Without Drain
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Over 18 years old
- Conservative surgery for breast cancer with associated axillary lymphadenectomy
You will not qualify if you...
- Mastectomy
- History of axillary surgery or ipsilateral axillary radiotherapy
- ASA 4 patients. (ASA 3 patients selected)
- Lack of adequate cognitive capacity and/or signed informed consent
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Maresme health consortium
Mataró, Spain
Actively Recruiting
Research Team
S
Sandra Lopez Gordo
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here